These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38649284)

  • 1. Modest effect of differential dietary vitamin A intake on the pathogenesis of alcohol-associated liver disease.
    Ferdouse A; Clugston RD
    Alcohol Clin Exp Res (Hoboken); 2024 Jun; 48(6):1036-1049. PubMed ID: 38649284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic-binge ethanol feeding aggravates systemic dyslipidemia in
    Hoebinger C; Rajcic D; Silva B; Hendrikx T
    Front Endocrinol (Lausanne); 2023; 14():1148827. PubMed ID: 37560305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retinoic acid receptor β2 agonist protects against alcohol liver disease and modulates hepatic expression of canonical retinoid metabolism genes.
    Melis M; Tang XH; Attarwala N; Chen Q; Prishker C; Qin L; Gross SS; Gudas LJ; Trasino SE
    Biofactors; 2022 Mar; 48(2):469-480. PubMed ID: 34687254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
    Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
    Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication.
    Israelsen M; Kim M; Suvitaival T; Madsen BS; Hansen CD; Torp N; Trost K; Thiele M; Hansen T; Legido-Quigley C; Krag A;
    JHEP Rep; 2021 Oct; 3(5):100325. PubMed ID: 34401690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism.
    Buyco DG; Dempsey JL; Scorletti E; Jeon S; Lin C; Harkin J; Bayen S; Furth EE; Martin J; Delima M; Hooks R; Sostre-Colón J; Gharib SA; Titchenell PM; Carr RM
    PLoS One; 2023; 18(5):e0281954. PubMed ID: 37134024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of Alcohol-Associated Fatty Liver: Lessons From Transgenic Mice.
    Ferdouse A; Clugston RD
    Front Physiol; 2022; 13():940974. PubMed ID: 35864895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Hepatotoxicity by a LXR Inverse Agonist in a Model of Alcoholic Liver Disease.
    Sengupta M; Griffett K; Flaveny CA; Burris TP
    ACS Pharmacol Transl Sci; 2018 Sep; 1(1):50-60. PubMed ID: 31696159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
    Satishchandran A; Ambade A; Rao S; Hsueh YC; Iracheta-Vellve A; Tornai D; Lowe P; Gyongyosi B; Li J; Catalano D; Zhong L; Kodys K; Xie J; Bala S; Gao G; Szabo G
    Gastroenterology; 2018 Jan; 154(1):238-252.e7. PubMed ID: 28987423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FXR overexpression prevents hepatic steatosis through inhibiting AIM2 inflammasome activation in alcoholic liver disease.
    Li L; Kong L; Xu S; Wang C; Gu J; Luo H; Meng Q
    Hepatol Int; 2024 Feb; 18(1):188-205. PubMed ID: 38183609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
    You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
    J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Abelson Tyrosine-Protein Kinase 2 Suppresses the Development of Alcohol-Associated Liver Disease by Decreasing PPARgamma Expression.
    Malnassy G; Keating CR; Gad S; Bridgeman B; Perera A; Hou W; Cotler SJ; Ding X; Choudhry M; Sun Z; Koleske AJ; Qiu W
    Cell Mol Gastroenterol Hepatol; 2023; 16(5):685-709. PubMed ID: 37460041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a crossed high alcohol preferring (cHAP) mouse model with the NIAAA-model of chronic-binge ethanol intake to study liver injury.
    Thompson KJ; Nazari SS; Jacobs WC; Grahame NJ; McKillop IH
    Alcohol Alcohol; 2017 Nov; 52(6):629-637. PubMed ID: 29036399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Methylnicotinamide promotes hepatic steatosis in mice: A potential mechanism in chronic alcohol-induced fatty liver disease.
    Lai S; Ma Y; Hao L; Ding Q; Chang K; Zhuge H; Qiu J; Xu T; Dou X; Li S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Apr; 1868(4):159286. PubMed ID: 36690322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effect of low-carbohydrate high-fat dietary pattern on liver disease caused by alcohol consumption
    Qiu J; Dong F; Zhuge H; Han Q; Li J; Guo R; Dou X; Li J; Li S
    Food Funct; 2024 Jan; 15(2):732-746. PubMed ID: 38117162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver-adipose tissue crosstalk in alcohol-associated liver disease: The role of mTOR.
    Rodriguez Y; Dunfield J; Roderique T; Ni HM
    Liver Res; 2022 Dec; 6(4):227-237. PubMed ID: 37124481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
    Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
    J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic basis of ethanol-induced hepatic and pancreatic injury in hepatic alcohol dehydrogenase deficient deer mice.
    Bhopale KK; Wu H; Boor PJ; Popov VL; Ansari GA; Kaphalia BS
    Alcohol; 2006 Jul; 39(3):179-88. PubMed ID: 17127137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR.
    Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q
    Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.